Lithuanian innovators Laurynas Karpus, Vykintas Jauniškis, and Irmantas Rokaitis have developed an AI-powered platform called Intelligent Architecture™ that generates custom enzymes, overcoming the limitations of traditional enzyme design. Their company, Biomatter, aims to revolutionize enzyme engineering for industrial and medical applications, contributing to sustainability and health. Their work aligns with the United Nations Sustainable Development Goals and positions them as leaders in the enzyme market, which is projected to grow significantly by 2034.